HARROW, INC. — Director's Dealing 2019

Mar 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARROW HEALTH, INC. (HROW)
CIK: 0001360214
Period of Report: 2019-03-01

Reporting Person: Kammer Robert J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-01	Common Stock	S	10000	$6.91	Disposed	859827	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan, as amended, adopted by the Reporting Person.